Effective Low-Cost Chemotherapy for Advanced Gastric Cancer
Author Information
Author(s): Cascinu S, Baldelli A M, Catalano V, Giordani P, Beretta G D, Silva R R, Gasparini G, Mari D, Maisano R, Salvagni S, Barni S, Labianca R, Frontini L, Curti C, Catalano G
Hypothesis
Can a simplified chemotherapy regimen using infusional 5-fluorouracil, cisplatin, and mitomycin C be effective in treating advanced gastric cancer?
Conclusion
The combination of cisplatin, 5-fluorouracil, and mitomycin C is an effective and safe treatment for advanced gastric cancer, with a response rate of 46.7% and a median survival of 11 months.
Supporting Evidence
- Five patients had a complete response and 16 had a partial response.
- The overall response rate was 46.7%.
- The median survival was 11 months.
- Grades 3–4 toxicities included mainly neutropenia and thrombocytopenia.
Takeaway
Doctors tested a new, cheaper way to treat stomach cancer and found it worked well for many patients.
Methodology
Patients with advanced gastric cancer received a regimen of cisplatin, 5-fluorouracil, and mitomycin C, with response and toxicity evaluated over multiple cycles.
Potential Biases
The study may have bias due to its non-randomized nature and the specific patient selection criteria.
Limitations
The study's non-randomized design suggests caution in interpreting the results.
Participant Demographics
Patients were required to be aged 70 or younger with measurable disease and normal organ function.
Statistical Information
Confidence Interval
95% CI, 32.1–61.2%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website